Effect of antidepressant agents on beta-adrenergic receptor and neurotransmitter regulatory systems.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D004082:Dihydroalprenolol; D004298:Dopamine / Q000378:metabolism; D007700:Kinetics; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D018377:Neurotransmitter Agents / Q000502:physiology*; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects*; D012701:Serotonin / Q000378:metabolism; D013574:Synaptosomes / Q000378:metabolism
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D018377:Neurotransmitter Agents; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D012701:Serotonin; D004082:Dihydroalprenolol; D004298:Dopamine; D009638:Norepinephrine